lobbying_activities: 2867497

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2867497	a5aebe22-cc6f-4bd4-ac1c-368209ea5ce0	Q3	RICCHETTI INCORPORATED	62778	IPSEN BIOPHARMACEUTICALS, INC.	2022	third_quarter	PHA	Issues related to pharmaceutical industry, generally; Issues related to development of products to treat limb spasticity and fibrodysplasia ossificans progressiva (FOP)	HOUSE OF REPRESENTATIVES,SENATE	20000		0	0	2022-10-17T11:27:58-04:00